Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome
Cardiovascular disease (CVD) is highly prevalent in the setting of chronic kidney disease (CKD). Such coexistence of CVD and CKD—the so-called “cardiorenal or renocardiac syndrome”—contributes to exponentially increased risk of cardiovascular (CV) mortality. U...
Main Author: | Suree Lekawanvijit |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-09-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/10/9/352 |
Similar Items
-
Adsorption- and Displacement-Based Approaches for the Removal of Protein-Bound Uremic Toxins
by: Flávia S. C. Rodrigues, et al.
Published: (2023-01-01) -
The Medium Cut-Off Membrane Does Not Lower Protein-Bound Uremic Toxins
by: Yang Gyun Kim, et al.
Published: (2022-11-01) -
Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence
by: Jia-Huang Chen, et al.
Published: (2021-12-01) -
Correlation between Saliva Levels and Serum Levels of Free Uremic Toxins in Healthy Volunteers
by: Nicolas Fabresse, et al.
Published: (2023-02-01) -
Protein-Bound Uremic Toxins Lowering Effect of Sevelamer in Pre-Dialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized Controlled Trial
by: Kullaya Takkavatakarn, et al.
Published: (2021-09-01)